|
|
Article: FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years.
- Article from:
- PR Newswire
- Article date:
- April 30, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- New Treatment Has Shown Benefit in Both Nasal and Ocular Symptoms in Seasonal Allergy Patients 12 Years of Age and Older -
RESEARCH TRIANGLE PARK, N.C., April 30 /PRNewswire/ -- The U.S. Food and Drug Administration approved once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray on Friday to treat seasonal and year-round allergy symptoms in adults and children two years of age and older. Veramyst will be available by prescription nationwide by late May 2007.
In clinical trials, Veramyst relieved overall nasal symptoms of seasonal and year-round allergies, which included nasal congestion, sneezing, itchy nose and runny nose. In addition, Veramyst ...